Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Certain genetic markers can indicate a person's risk of developing prostate cancer.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Obese women with PCOS are more likely to have fatty liver disease.

The spironolactone cream did not reduce hair growth in women with hirsutism.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Blocking androgens in male rats increased estrogen and made them more active.

Blocking androgens at birth reduces sexual motivation in male rats.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.